Bristol-Myers Squibb: Clinical Trials
 
Clinical Trials Bristol-Myers Squibb invested $3.9 billion in 2012 to discover and develop innovative medicines to help patients prevail against serious diseases.

In the past several years, we have delivered a number of new products for patients in need, including medicines for rheumatoid arthritis, hepatitis B, cancer, HIV/AIDS and diabetes. As we look to the future, our pipeline continues to expand as we have more than 60 investigational compounds in development, of which, about one-third are biologics. Below is a list of the therapeutic areas we concentrate in:

  • Cardiovascular
  • Immunoscience
  • Metabolics
  • Oncology
  • Virology

In the true spirit of science, we are dedicated to educating and sharing our clinical trials information and data with patients, medical/research communities, the media, policy makers and the general public. We act on our belief that the priceless ingredient of every product is the integrity of its maker.

 
 
Patients and
Caregivers



To learn more about new or currently enrolling clinical trials, please visit:
Bristol-Myers Squibb
Study Connect
General Public

Clinical Trials For additional information on all completed, active and not yet recruiting Bristol-Myers Squibb sponsored clinical trials, visit: ClinicalTrials.gov.
 
 


You are leaving BMS.com to go to the Amylin Job Search and application tool. IMPORTANT TO NOTE: This may require a separate login and password than what is used for the Bristol-Myers Squibb search and application process.
You are leaving BMS.com to go to the Amylin Job Search and application tool. IMPORTANT TO NOTE: This may require a separate login and password than what is used for the Bristol-Myers Squibb search and application process.